1. Home
  2. NBY vs NEPH Comparison

NBY vs NEPH Comparison

Compare NBY & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.95

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$2.88

Market Cap

31.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBY
NEPH
Founded
2000
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.6M
31.0M
IPO Year
2007
2004

Fundamental Metrics

Financial Performance
Metric
NBY
NEPH
Price
$1.95
$2.88
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
764.8K
43.3K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
35.42
1000.00
EPS
0.76
0.11
Revenue
$370,000.00
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
$2.57
$26.45
Revenue Growth
N/A
32.67
52 Week Low
$0.43
$1.78
52 Week High
$19.95
$6.42

Technical Indicators

Market Signals
Indicator
NBY
NEPH
Relative Strength Index (RSI) 57.82 35.77
Support Level $1.01 $2.79
Resistance Level $2.52 $3.21
Average True Range (ATR) 0.26 0.17
MACD 0.11 0.03
Stochastic Oscillator 96.45 25.06

Price Performance

Historical Comparison
NBY
NEPH

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: